Manufacturer of Controlled Substances; Notice of Registration, 43813 [E6-12478]
Download as PDF
<![CDATA[
wwhite on PROD1PC61 with NOTICES
Federal Register / Vol. 71, No. 148 / Wednesday, August 2, 2006 / Notices
43813
Final Judgments would serve the public
interest. Copies of the AWA’s and
Foote’s joint motion to terminate, the
stipulation containing the United States’
tentative consent, the United States’
memorandum, and all further papers
filed with the Court in connection with
the AWA’s and Foote’s joint motion will
be available for inspection at the
Antitrust Documents Group, Antitrust
Division, Room 215, 325 7th Street,
NW., Washington, DC 20004, and at the
Office of the Clerk of the United States
District Court for the Southern District
of New York. Copies of these materials
may be obtained from the Antitrust
Division upon request and payment of
the copying fee set by Department
regulations.
Interested persons may submit
comments regarding the proposed
termination of the AWA and Foote Final
Judgments to the United States. Such
comments must be received by the
Antitrust Division within sixty (60) days
and will be filed with the Court by the
United States. Comments should be
addressed to John R. Read, Chief,
Litigation III Section, Antitrust Division,
U.S. Department of Justice, 325 7th
Street, NW., Suite 300, Washington, DC
20530.
Schedule
manufacturers and sellers of Swiss
watches and watch parts engaged in a
conspiracy ‘‘to restrict, eliminate and
discourage the manufacture of watches
and watch parts in the United States,
and to restrain United States imports
and exports of watches and watch parts
for manufacturing and repair purposes.’’
Id. The United States also charged that
these companies agreed to fix minimum
prices for watches and maximum prices
for repair parts, regulate the use and
distribution of watches and repair parts,
boycott those who violated these
restrictions. Id. The conspiracy came
about through the adoption and
enforcement of an agreement known as
the Collective Convention of the Swiss
Watch Industry. ‘‘The purpose of the
Collective Convention was to protect,
develop and stablize the Swiss watch
industry and to impede the growth and
competitive watch industries outside of
Switzerland.’’ United States v. The
Watchmakers of Switzerland
Information Center, Inc., 1963–1 Trade
Cas. (CCH) ¶70,600, at 77,426 (S.D.N.Y.
Dec. 20, 1962).
The AWA was named as a defendant
because, as a trade association whose
members included most of the
defendant manufacturers and importers,
there was concern that the AWA could
aid the alleged conspiracy by policing
members’ conduct and influencing
members to participate in the cartel.
Foote was named as a defendant in
the Complaint, becuase as an
advertising agency and an agent for
some of the defendants, there was
concern that Foote, similar to the AWA,
was policing the alleged conspiracy and
thus aiding the defendants in the
enforcement of the cartel.
On March 9, 1960, prior to trial, the
United States and the defendant
importers (not the AWA since it is a
trade association, nor Foote since it is
an advertising agency) named in the
complaint agreed to enter into the
Watchmakers Final Judgment in lieu of
going to trial. United States v. The
Watchmakers of Switzerland
Information Center, Inc., Trade Reg.
Rep. (CCH) ¶69,655 (S.D.N.Y. Mar. 9,
1960). Also on March 9, 1960, the
United States and Defendants AWA and
Foote agreed to enter into the AWA
Final Judgment and the Foote Final
Judgment, respectively, in lieu of going
to trial. Id. Most of the restrictions in the
AWA and Foote Final Judgments
prohibit conduct that each company,
respectively, could have taken to
facilitate the conspiracy.
The Department has filed with the
Court a memorandum setting forth the
reasons why the United States believes
that termination of the AWA and Foote
VerDate Aug<31>2005
16:40 Aug 01, 2006
Jkt 208001
Dorothy B. Fountain,
Deputy Director of Operations, Antitrust
Division.
[FR Doc. 06–6625 Filed 8–1–06; 8:45 am]
BILLING CODE 4410–11–M
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration
By Notice dated March 20, 2006 and
published in the Federal Register on
March 24, 2006, (71 FR 14948),
Cerilliant API Services LLC, 811 Paloma
Drive, Suite A, Round Rock, Texas
78664, made application to the Drug
Enforcement Administration (DEA) to
be registered as a bulk manufacturer of
the basic classes of controlled
substances listed in Schedule I and II;
and by letter to modify its name to
Austin Pharma LLC. Subsequent to the
publication of the Notice of Application,
by letter, the company has also
requested to withdraw thirty-five drug
codes from their initial application
request.
Drug
Schedule
Marihuana (7360) .........................
Tetrahydrocannabinols (7370) .....
Alphamethadol (9605) ..................
PO 00000
Frm 00104
Fmt 4703
Sfmt 4703
I
I
I
Drug
Methadone (9250) ........................
Methadone intermediate (9254) ...
Levo-alphacetylmethadol (9648) ..
Alfentanil (9737) ...........................
Remifentanil (9739) ......................
Sufentanil (9740) ..........................
Fentanyl (9801) ............................
II
II
II
II
II
II
II
The company plans to manufacture
the listed controlled substances in bulk
for distribution to its customers.
In reference to drug code 7360
(Marihuana), the company plans to bulk
manufacture cannabidiol as a synthetic
intermediate. This controlled substance
will be further synthesized to bulk
manufacture a synthetic THC (7370). No
other activity for this drug code is
authorized for this registration.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Cerilliant API Services LLC to
manufacture the listed basic classes of
controlled substances is consistent with
the public interest at this time. DEA has
investigated Cerilliant API Services LLC
to ensure that the company’s
registration is consistent with the public
interest. The investigation has included
inspection and testing of the company’s
physical security systems, verification
of the company’s compliance with state
and local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
Dated: July 26, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E6–12478 Filed 8–1–06; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Application
Pursuant to Section 1301.33(a) of Title
21 of the Code of Federal Regulations
(CFR), this is notice that on June 22,
2006, Clariant LSM (Missouri) Inc., 2460
W. Bennett Street, or (P.O. Box 1246, zip
65801), Springfield, Missouri 65807–
1229, made application by renewal to
the Drug Enforcement Administration
(DEA) to be registered as a bulk
manufacturer of the basic classes of
E:\FR\FM\02AUN1.SGM
02AUN1
]]>Agencies
[Federal Register Volume 71, Number 148 (Wednesday, August 2, 2006)]
[Notices]
[Page 43813]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-12478]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated March 20, 2006 and published in the Federal
Register on March 24, 2006, (71 FR 14948), Cerilliant API Services LLC,
811 Paloma Drive, Suite A, Round Rock, Texas 78664, made application to
the Drug Enforcement Administration (DEA) to be registered as a bulk
manufacturer of the basic classes of controlled substances listed in
Schedule I and II; and by letter to modify its name to Austin Pharma
LLC. Subsequent to the publication of the Notice of Application, by
letter, the company has also requested to withdraw thirty-five drug
codes from their initial application request.
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Marihuana (7360)........................... I
Tetrahydrocannabinols (7370)............... I
Alphamethadol (9605)....................... I
Methadone (9250)........................... II
Methadone intermediate (9254).............. II
Levo-alphacetylmethadol (9648)............. II
Alfentanil (9737).......................... II
Remifentanil (9739)........................ II
Sufentanil (9740).......................... II
Fentanyl (9801)............................ II
------------------------------------------------------------------------
The company plans to manufacture the listed controlled substances
in bulk for distribution to its customers.
In reference to drug code 7360 (Marihuana), the company plans to
bulk manufacture cannabidiol as a synthetic intermediate. This
controlled substance will be further synthesized to bulk manufacture a
synthetic THC (7370). No other activity for this drug code is
authorized for this registration.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and determined that the registration of
Cerilliant API Services LLC to manufacture the listed basic classes of
controlled substances is consistent with the public interest at this
time. DEA has investigated Cerilliant API Services LLC to ensure that
the company's registration is consistent with the public interest. The
investigation has included inspection and testing of the company's
physical security systems, verification of the company's compliance
with state and local laws, and a review of the company's background and
history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with
21 CFR 1301.33, the above named company is granted registration as a
bulk manufacturer of the basic classes of controlled substances listed.
Dated: July 26, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E6-12478 Filed 8-1-06; 8:45 am]
BILLING CODE 4410-09-P
